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There is growing evidence that factors encoded by cytoplasmic replicating viruses
functionally interact with components of the nucleocytoplasmic transport apparatus. They
do so either to access the cell nucleus, thus affecting genes expression, or to interfere with
nuclear transport functionality, hindering host immune response. Recent studies revealed
that the hepatitis C virus (HCV) makes no exception, interacting with the host cell nuclear
transport machinery at two different levels. On the one hand, small amounts of both core
and NS5A localize within the host cell nucleus during productive infection, modulating
gene expression and signaling functions to promote persistent infection. On the other
hand, HCV infection causes a profound redistribution of certain nucleoproteins to the
close proximity of endoplasmic reticulum membrane-derived viral replication factories,
where viral RNA amplification occurs. These nucleoporins are believed to form nuclear
pore complex-like structures, as suggested by their ability to recruit nuclear localization
sequence-bearing proteins. Thus, both processes are linked to virus-induced persistence
and pathogenesis, representing possible targets for the development of novel anti-HCV
therapeutics.
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Nuclear Transport
The eukaryotic nucleus is separated from the cytoplasm by a double membrane called nuclear
envelope (NE). Nucleocytoplasmic transport occurs through NE-embedded nuclear pore complexes
(NPCs). Cargoes>9 nm indiameter (60 kDa) are actively transported throughNPCs by kariophilic
transporters (Kaps) in a signal-mediated process. Such signals can be either nuclear localization or
nuclear export sequences (NLSs and NESs), responsible for targeting into and out of the nucleus
as mediated by importins (IMPs) or exportins (EXPs), respectively (Tran et al., 2007). Several
types of NLSs exist, differing in their sequence and IMP-binding properties. Short, basic NLSs
similar to that of the Simian Virus 40 Large Tumor Antigen (Tag) are referred to as “classical”
NLSs (Kalderon et al., 1984). Such signals are recognized by IMPb1 (IPO1) via one of the seven
IMPa family members (IPOA1, IPOA3-8), which are classified in three subgroups according to
their homology and cargo-binding specificity (Alvisi and Jans, 2015). Alternatively, IMPb1 and
its homolog can also bind cargoes directly without the need of IMPas (Truant and Cullen, 1999;
Fontes et al., 2000; Chook and Suel, 2011). These include IMPb2 (IPO2), mainly responsible for
importing RNA-binding proteins, and IMPb3 (IPO5), involved in transport of core histones and
ribosomal proteins (Jakel andGorlich, 1998). All IMPb homolog share similar mechanisms for cargo
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nuclear transport and release. Assembly of cargo-IMP
complexes results in docking to the NPC, as mediated by
IMPb interaction with specific nucleoporins (Nups), followed by
NPC translocation. Once inside the nucleus, binding of Ran-GTP
to IMPb mediates a conformational change, resulting in the
dissociation of the complexes (Cansizoglu et al., 2007; Imasaki
et al., 2007). Conversely, EXPs such as CRM-1 (XPO1) recognize
NES-bearing cargoes in the nucleus upon binding to Ran-GTP,
and translocate to the cytosol.
Nuclear replicating viruses interact with the nuclear transport
apparatus to ensure nuclear targeting of viral replicating enzymes
(Alvisi et al., 2011b, 2013). Strikingly, several proteins encoded
by cytoplasmic-replicating viruses similarly interact with the
nuclear transport apparatus, mainly with the aim to interfere with
host cell functionality, promoting their self-propagation (Camus-
Bouclainville et al., 2004; Zhang et al., 2007; Alvisi et al., 2008;
Wang et al., 2012). Among these, the hepatitis C virus (HCV)
makes no exception.
Hepatitis C Virus
Hepatitis C virus is a cytoplasmic-replicating RNA virus
belonging to the Flaviviridae family. Once inside the host cell,
its 9.6 Kbp genome is translated on the rough endoplasmic
reticulum (ER) into a single polyprotein of about 3000 amino
acids, co- and post-translationally cleaved by viral and host
proteases into three structural proteins (core, E1, and E2),
the viroporin p7, and six non-structural proteins (NS2, NS3,
NS4A, NS4B, NS5A, and NS5B; Kato, 2000). Core, E1 and E2
constitute the viral particle, p7 and NS2 are involved in virion
assembly and release, while NS3 to NS5B proteins are sufficient
for RNA replication (Lohmann et al., 1999; Jones et al., 2007;
Steinmann et al., 2007). Expression of the HCV polyprotein
induces profound membrane rearrangements, including the
formation of double membrane vesicles (DMVs) where viral
proteins and host factors are recruited to replicate viral RNA
(Romero-Brey et al., 2012). Such membrane alterations, i.e.,
viral replication factories (VFs), are common amongst positive-
stranded RNA viruses, and are surrounded by autophagosomes
and lipid droplets (LDs) in the case of HCV infection. Although
their precise structure and function are still not completely
clear, they support viral infection by a variety of mechanisms
(Paul and Bartenschlager, 2013), such as by tethering the viral
RNA during unwinding (Lyle et al., 2002) and by ensuring
compartmentalization and concentration of viral products (Paul
and Bartenschlager, 2013). VFs also provide lipids essential
for replication (Ahola et al., 1999), and facilitate avoidance of
host cell cytoplasmic pattern recognition receptors crucial for
initiating antiviral immune responses (Overby et al., 2010).
Furthermore, HCV-induced VFs have been recently shown
to protect viral RNA from double strand RNA-induced host
defenses and nucleases (Paul et al., 2013). Upon HCV infection,
development of VFs is mainly dependent on NS4B and NS5A,
the latter being responsible for DMV biogenesis via stimulation
of the type III phosphatidylinositol 4-kinase a (PI4KIIIa; Reiss
et al., 2011; Berger et al., 2014). Activated PI4KIIIa causes a
profound redistribution of phosphatidylinositol-4 phosphate
from the plasma membrane to VFs, where RNA polymerase
NS5B-mediated HCV RNA replication occurs (Lohmann et al.,
1999; Bianco et al., 2012). Newly synthesized viral genomes are
subsequently delivered by NS5A on the surface of core-decorated
LDs to be packaged in nucleocapsids, before being secreted
through the very low density lipoprotein pathway (Miyanari
et al., 2007; Gastaminza et al., 2008; Alvisi et al., 2011a). Although
HCV life cycle has no clear nuclear intermediate, certain HCV
proteins contain multiple functional NLSs and NESs, and interact
with several Kaps (Figure 1; Chung et al., 2000; Germain et al.,
2014; Levin et al., 2014). This redundancy of signals probably
reflects the need for certain HCV proteins to be functionally
targeted to different subcellular compartments according to
specific stages of HCV life cycle. This would be consistent with
the very recent discovery that HCV infection causes partial
redistribution of certain Nups to the close proximity of VFs that
are the sites of NLS-bearing cargo recruitment (Neufeldt et al.,
2013; Levin et al., 2014).
Functional Role of NS5A and Core Within
the Cell Nucleus
So far, among all the HCV proteins bearing functional
NLSs/NESs, insights into nuclear function has been delineated
only for the NS5A and the core protein. NS5A is a multifunctional
phosphoprotein directly involved in multiple stages of viral life
cycle, includingVFs biogenesis, viral RNA replication and particle
assembly (Shimakami et al., 2004; Masaki et al., 2008; Reiss et al.,
2011). Consequently, NS5A has been proposed to act as a master
regulator of HCV life cycle, controlling the switch between viral
replication and particle assembly through a still uncharacterized
phosphorylation-dependent mechanism (Masaki et al., 2008).
Additionally, NS5A affects a number of host cell signaling
pathways, as exemplified by its ability to interact with several
cellular proteins and regulate their activities (Pichlmair et al.,
2012; Eberle et al., 2014). NS5A nuclear role seems to be primarily
linked to HCV ability to establish a persistent infection, avoiding
the host cell response and simultaneously enhancing the cellular
survival ability (Figure 2). Indeed, nuclear NS5A impairs both
interferon (IFN) antiviral and apoptotic pathways (Khabar et al.,
1997; Ghosh et al., 1999; Majumder et al., 2001). NS5A bears a
C-terminally-located NLS (Figure 1), which interacts with IPO5
and confers nuclear localization when fused to heterologous
proteins (Ide et al., 1996; Chung et al., 2000; Levin et al., 2014).
However, full-length NS5A is tethered to the ER by its N-terminal
amphipathic a-helix (AH), which prevents nuclear translocation
(Elazar et al., 2003). Importantly, NS5A contains two caspase
cleavage sites at residue position 154 and 389 (Figure 1). In
HCV-infected cells, basal caspase activity generates low levels of
NS5A truncated forms in the absence of apoptotic stimuli. These
include nuclear-accumulating fragments containing the NLS but
lacking the AH, which bind the promoters of interleukin-8 (a
negative regulator of the IFN pathway), as well as of the apoptosis
inhibitors lymphotoxin beta and NUAK2, up-regulating their
transcription (Satoh et al., 2000; Legembre et al., 2004; Haybaeck
et al., 2009; Sauter et al., 2009; Maqbool et al., 2013). NS5A ability
to migrate to the nucleus and modulate host gene expression
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FIGURE 1 | HCV proteins contain functional nuclear transport signals
(NTSs). (A) A summary of HCV proteins binding to Kaps, as well as the
sequences of identified NTSs. Basic residues within NLSs are in boldface;
hydrophobic residues within NESs are underlined; the single letter amino
acid code is used; *protein that can be detected within the host cell nucleus
during viral infection. (B) Schematic representation of core and NS5A
proteins, their functional domains as well as their NTSs and the Kap-binding
sites.
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FIGURE 2 | Possible relationship between nuclear transport
apparatus and HCV life cycle. (A) Soon after HCV infection, core is
transported into the nucleus to promote ribosome biogenesis. Newly
synthesized viral proteins promote VF development, depending on
NS5A-mediated recruitment of PI4KIIIa. Simultaneously, specific Nups are
recruited by core and NS5A to VFs. (B) Small amounts of NS5A reach the
nucleus after being processed by basal caspase activity, resulting in
activation of a specific transcriptional program aimed at inhibiting IFN
response and apoptosis. Core migrates to the nucleus to be degraded by
PA28g instead, thus stabilizing cytoplasmic core. (C) Viral replication
progresses and specific host factors are recruited to VFs, either directly by
viral proteins or indirectly by IMPs recognizing IPO5-dependent NLSs. (D)
Strong viral replication and production eventually causes oxidative stress and
lipid peroxidation that is detrimental to host cells, leading to activation of
caspase activity and NS5A nuclear accumulation, thereby sequestering the
host dependency factor c-Raf from VFs. This impairs viral replication and the
pro-apoptotic factor Bax, thus promoting infected cells survival, viral
reactivation, and liver damage.
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appears to be important for HCV life cycle. Indeed, the degree of
transcriptional activation mediated by different NS5A variants
correlates with the levels of viral replication in the HCV replicon
system. Furthermore, pharmacological ablation of caspase
activity negatively affected HCV genome replication, preventing
NS5A nuclear translocation (Maqbool et al., 2013). Besides
transcriptional regulation, nuclear NS5A promotes cell survival
also by preventing translocation of the apoptotic activator Bcl-2
associated X protein (Bax) to the nuclear membrane in response
to cellular stress, thus mitigating its pro-apoptotic function
(Chung et al., 2003; Ruggieri et al., 2012; Lindenboim et al., 2014).
Furthermore, it has been recently shown that overexpression of
NS5A N-terminally truncated forms impairs HCV replication,
by relocalizing the host dependency factor c-Raf from VFs to cell
nuclei (Sauter et al., 2009). Since c-Raf facilitates viral replication
through attenuation of the IFN pathway, its withdrawal from
VFs impairs HCV replication (Zhang et al., 2012). These findings
probably reflect an auto-inhibitory mechanism evolved by HCV
to reduce its own replication in case of virus-induced cellular
stress, thus preventing apoptosis and promoting persistent
infection. This is consistent with the ability of several HCV
genotypes to decrease viral replication levels once viral-induced
lipid peroxidation threatens cell viability (Yamane et al., 2014).
As mentioned above, important nuclear functions are also
emerging for the core protein, a small structural protein forming
the viral nucleocapsid and undergoing multiple maturation steps.
Upon translation on the rough ER, core protein is initially cleaved
from the nascent polyprotein by the host cell signal peptidase.
This immature form of core is anchored to the ER-membrane by
a C-terminal signal peptide, which facilitates translocation of the
polyprotein into the ER lumen. Subsequently, it is cleaved by the
intermembrane host cell signal peptide peptidase between residue
177 and 178 to enable the mature form of core to migrate on
LDs (Ogino et al., 2004; Hope et al., 2006; Okamoto et al., 2008).
Once there, core encapsidates newly generated viral genomes in
concerted action with other viral proteins such as NS5A, NS2
and p7 (Appel et al., 2008; Stapleford and Lindenbach, 2011).
In contrast to its predominantly cytoplasmic localization upon
overexpression in cell culture or in productively infected cells
in vitro, the core protein has been detected in the nucleus of
hepatocytes of chronically infected patients and core transgenic
mice (Moriya et al., 1997). Indeed, it contains four N-terminally
located NLSs and two C-terminally located NESs (Figure 1).
Such signals are functional, conferring both nuclear shuttling and
Kap-binding abilities to reporter proteins (Cerutti et al., 2011;
Levin et al., 2014). Importantly, immuno-electron microscopic
analysis of HCV-infected hepatocytes allowed detection of small
amounts of core into the cell nucleus 20 min post-infection.
Additionally, core could also be observed in the nucleus later
on, upon pharmacological inhibition of CRM-1, indicating that
both NES and NLS are functional in the context of productively
infected hepatocytes. Intriguingly, core could be detected in the
nucleus in the absence of CRM-1 inhibition also upon knock-
down of the proteasome activator PA28, which is responsible
for ubiquitin-independent degradation of core in the cell nuclei.
PA28 inactivation also caused increase in the ubiquitination of
cytoplasmic core, and impaired viral assembly (Moriishi et al.,
2010; Cerutti et al., 2011). Indeed, core can be degraded both
in the nucleus in an ubiquitin-independent manner, and in the
cytosol through an ubiquitin-dependent process involving the E3
ubiquitin ligase E6AP (Suzuki et al., 2009; Shoji, 2012). Therefore,
nuclear activation of PA28 by core inhibits E6AP, resulting in
increased overall core stability and promoting viral assembly and
release (Moriishi et al., 2010). Additionally, core is endowed with
transcriptional activity, and represents the only HCV protein
globally regulating host cell transcription, by directly binding the
TATA-binding protein (Moriishi et al., 2003; Kao et al., 2004). This
transcriptional stimulation is further supported by the ability of
core to promote ribosome biogenesis, supporting cell growth and
viral replication through epigenetic enhancement of the nucleolar
protein B23 transcription. Indeed, core can recruit the histone
acetyltransferase p300 at the B23 promoter (Mai et al., 2006). In
addition, nuclear core also inhibits transcription of genes linked to
apoptosis, by up-regulating the expression of inhibitor of caspase-
activated DNase (Sacco et al., 2003).
Therefore, both core and NS5A can localize in the cell nucleus
and modulate transcription, promoting cell survival. In addition,
NS5A also promotes immune evasion, while core specifically
increases the translation rate of infected cells via increased
ribosome biogenesis.
Cytosolic Relocalization of Nups Upon
HCV Infection
Hepatitis C virus VFs are a separate compartment from the
cytoplasm (Miyanari et al., 2003; Hsu et al., 2010). Although the
existence of a selective permeable barrier between the VF lumen
and the surrounding cytoplasm has been postulated long ago,
functional proof lacked until very recently (Neufeldt et al., 2013).
Eventually, its definition has allowed reconciling the lack of HCV
nuclear replication intermediate with the presence of functional
NLSs and NESs within HCV proteins that are not observed in the
nucleus during viral life cycle (Levin et al., 2014).
Various HCV proteins interact with high affinity nuclear
transport factors (NTFs), although only core and NS5A
functionally localize, to some extent, in the cell nuclei during viral
infection (Moriya et al., 1997; Sauter et al., 2009; Cerutti et al.,
2011;Maqbool et al., 2013; Germain et al., 2014; Levin et al., 2014).
These findings suggested that HCVprotein interaction withNTFs
might be broader than originally thought.Mounting experimental
evidence suggests that functional NPC-like structures could be
recruited by HCV within the cytoplasmic VFs to build up a
permeability barrier that improves the viral fitness (Neufeldt
et al., 2013). While similar structures have been previously
described within several cell types and are induced by other
viruses, their functional characterization has begun only recently,
using the HCV infectious system (Merisko, 1989; Marshall et al.,
1996; Wang et al., 1997; Neufeldt et al., 2013). In particular,
Nups representing most of the major NPC subcomplexes formed
cytoplasmic foci upon HCV infection, and either co-localized
or physically interacted with core and NS5A. Interestingly,
this redistribution is associated with up-regulation at both the
mRNA and protein level of specific Nups, further supporting
the previously described HCV transcriptional regulation ability.
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Similarly, both IPOA5 and IPO5 partially relocalized to VFs
upon HCV infection and interacted with several HCV proteins,
although recruitment of Kaps to sites of HCV replication did
not correlate with their over-expression, as in the case of Nups.
Importantly, addition of NLS-mimicking peptides was sufficient
to prevent the interaction of core andNS5Awith IPO5/IPOA5 but
not with Nups, suggesting that the interaction of viral proteins
with Nups was NLS- and Kap-independent (Neufeldt et al.,
2013). Knock-down of Nups and Kaps revealed that different
NTFs play specific roles in HCV life cycle. Indeed, depletion
of Nup98 and 153 strongly impaired viral replication, whereas
down-regulation of Nup155 and IPO5 specifically affected viral
particle assembly. As mentioned above, several HCV proteins
have functional NLSs capable of interacting with different Kaps,
including IMPa and IMPb homolog such as IPOA5 and IPO5
(Germain et al., 2014; Levin et al., 2014). Intriguingly, addition of
cell permeable HCV NLS-mimicking peptides binding to specific
Kaps differently affected the outcome of viral infection. While
IPOA5-binding peptides specifically impaired viral replication,
IPO5-binding ones interfered with both viral replication and
assembly (Levin et al., 2014). Importantly, functionality of the
HCV-induced cytoplasmic Kap-Nup network was demonstrated
by the delocalization of the small GTPase Ran to NS5A
positive foci, and by the fact that such complexes were able
to recruit a specific subset of cargoes (Neufeldt et al., 2013;
Levin et al., 2014). Indeed, reporter proteins fused to IPOA5-
binding NLSs (such as Tag NLS) were efficiently transported
to core positive foci during productive infection, while IPO5-
binding NLSs (such as Rev NLS) were not. This raises the
possibility that IPOA5 and IPO5 may contribute to distinct
processes during the HCV life cycle, respectively allowing and
restricting trafficking of specific cargoes in and out of VFs
(Levin et al., 2014).
Overall, these findings would support the redirection of
Nups to cytoplasmic NPC-like structures and movement of
viral and host NLS-bearing proteins from the cytoplasm to the
lumen of VFs with the purpose to create isolated and protected
niches of viral replication and assembly (Figure 2). The VF-
associated NPCs could also be able to discriminate between
NTFs, importing IPOA5-shuttled proteins in a selective way and
excluding IPO5 cargos as well as NLS-lacking proteins from
the HCV replication complexes. Therefore, it is possible that
HCV exploits the nucleocytoplasmic transport system to target
specific cargoes of viral and cellular origin to the nucleus and
VFs. In this context, NS5A interaction with IPO5 would suggest
that NPC-like structures play a role in triggering the switch
between viral replication and assembly by restricting NS5A from
entering the VFs. Since infection causes a decrease in the levels
of nuclear accumulation of IPOA5-transported cargoes such as
GFP-Tag NLS by partially relocalizing them to core positive
foci, it is also possible that HCV-induced NPCs similarly impair
nuclear targeting of specific host factors such as p53 or STAT1,
thus interfering with their functions (Germain et al., 2014).
Indeed, altered host cell nuclear transport and functions are not
uncommon upon viral infections (Yarbrough et al., 2014).
It remains to be investigated how the two Kap-mediated
transport systems affect each other in HCV-infected hepatocytes
and whether trafficking to VFs differs from nuclear import at the
molecular level. For sure, the striking news about HCV life cycle
is that Nups do work outside the physiological environment of
the NE during viral infection. The molecular basis responsible
for functional and regulatory differences between the NPC-
dependent transport systems located on VFs or NE are elusive
at present (including the role of the GTPase Ran in VF import),
which requires further experimental efforts.
Conclusion
Detection of core- and NS5A-dependent transcriptional
regulation and of cellular NTF-HCV protein interactions suggests
that HCV exploits previously unidentified and nucleus-linked
mechanisms to regulate both its survival and liver damage.
These findings are consistent with the functionality of numerous
NLSs found on HCV proteins. On the one hand, these NLSs
are employed for protein shuttling to the nucleus. Consistently,
core and NS5A and/or their variants regulate the cellular
transcriptional environment, making it conductive to cell survival
and prone to persistent viral infection by promoting ribosome
biogenesis, and inhibiting IFN antiviral pathway and apoptotic
cell death. On the other hand, NPC-like structures are proposed
to form channels across the VF double membrane structures,
which arise upon the HCV-induced cytoplasmic redistribution of
Nups and Kaps. Selective trafficking across them regulates viral
infection during distinct phases of HCV life cycle, with IPOA5-
and IPO5-cargos being allowed or denied VF entry, respectively.
The further characterization of HCV trafficking signals has
the potential to support the design of selective viral NLS/NES-
targeted molecules with pangenotypic antiviral activity, targeting
conserved regions among the HCV genotypes. Potentially, the
same holds true for the discovery of new pieces of the cellular
transcriptional puzzle altered by HCV, which may further help to
forecast therapeutic outcomes after antiviral treatment.
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